Price $0.13 |
Market Cap
8.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.36
|
P/S
10.36
|
Dividend %
-
|
|
P/CF
0.5
|
P/FCF
-
|
Op. Cash Flow
-71.5K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-132.10%
|
ROI
-168.30%
|
|
ROA
-96.70%
|
EPS Growth
21.50%
|
Current Ratio
4.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LAVA Therapeutics NV (LVTX) | $2.51 | - | - | 49.9M | Strong Buy |
| Avinger Inc (AVGR) | $0.56 | - | - | 5.6M | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.17 | - | - | 106.5M | Strong Buy |
| PAVmed Inc (PAVM) | $0.44 | - | - | 44.4M | Strong Buy |
| Hexo Corp (HEXO) | $0.82 | - | - | 57.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
